Clinical Trial Update: Dose-ranging Study of SKF7™ for Obesity [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial of SKF7 for obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SKF7

Snippet

Sponsor: Indonesia University | Conditions: Obesity | Phase 2 | Status: COMPLETED